Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Village Super Market A | VLGEA | Jan 2, 2025 | 31.41 | -1.51 |
Vimeo | VMEO | Jan 2, 2025 | 6.48 | +1.25 |
Vince Holding | VNCE | Jan 2, 2025 | 3.89 | +6.87 |
Vincerx Pharma | VINC | Jan 2, 2025 | 0.24 | -10.46 |
Vinci Partners A | VINP | Jan 2, 2025 | 9.95 | -1.19 |
Vine Hill Capital Investment | VCIC | Jan 2, 2025 | 10.03 | 0.00 |
Vine Hill Capital Investment | VCICU | Jan 2, 2025 | 10.09 | 0.00 |
VinFast Auto | VFS | Jan 2, 2025 | 4.20 | +4.22 |
Viomi Technology ADR | VIOT | Jan 2, 2025 | 1.53 | +4.79 |
Viper Energy Partners | VNOM | Jan 2, 2025 | 49.87 | +1.63 |
Vipshop ADR | VIPS | Jan 2, 2025 | 13.07 | -2.97 |
Vir Biotechnology | VIR | Jan 2, 2025 | 7.27 | -0.95 |
Viracta Therapeutics | VIRX | Jan 2, 2025 | 0.18 | +9.94 |
Virax Biolabs | VRAX | Jan 2, 2025 | 2.21 | -1.78 |
Virco Manufacturing | VIRC | Jan 2, 2025 | 10.18 | -0.68 |
Virgin Galactic | SPCE | Jan 2, 2025 | 6.06 | +3.06 |
Virginia National Bank | VABK | Jan 2, 2025 | 36.83 | -3.59 |
Viridian Therapeutics | VRDN | Jan 2, 2025 | 19.76 | +3.08 |
Virios Therapeutics | VIRI | Jan 2, 2025 | 0.16 | 0.00 |
VirnetX | VHC | Jan 2, 2025 | 7.15 | -8.92 |
Virpax Pharmaceuticals | VRPX | Jan 2, 2025 | 0.37 | -1.42 |
VirTra | VTSI | Jan 2, 2025 | 6.83 | +1.19 |
Virtu Financial A | VIRT | Jan 2, 2025 | 36.07 | +1.09 |
Virtus AllianzGI Artificial Intelligence & Technology Opport | AIO | Jan 2, 2025 | 24.16 | -2.03 |
Virtus Allianzgi Diversified Income & Convertible Fund | ACV | Jan 2, 2025 | 22.02 | +0.32 |
Virtus Convertible & Fund | NCV | Jan 2, 2025 | 3.46 | -0.29 |
Virtus Convertible & Fund II | NCZ | Jan 2, 2025 | 3.12 | -0.32 |
Virtus Convertible And Income Fund | NCV-A | Jan 2, 2025 | 21.29 | +0.33 |
Virtus Convertible And Income Fund II | NCZ-A | Jan 2, 2025 | 20.42 | +0.84 |
Virtus Dividend Interest & Premium Strategy Fund | NFJ | Jan 2, 2025 | 12.68 | +0.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.